Sepsis Diagnostics Market is Projected To Reach A Revised Size of USD 528.8 Million By 2028, Growing At A CAGR Of 5.2% | Valuates Reports

BANGALORE, India, Jan. 17, 2023 /PRNewswire/ -- Sepsis Diagnostics Market is segmented By Type - Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, Biomarkers, By Application - Hospitals, Pathology & Reference Laboratories. Global Opportunity Analysis and Industry Forecast, 2022 – 2028.

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global Sepsis Diagnostics market estimated at USD 390.1 million in the year 2022, is projected to reach a revised size of USD 528.8 million by 2028, growing at a CAGR of 5.2% during the forecast period 2022-2028.

The Major Factor Driving The Growth Of The Sepsis Diagnostics Market Are

The growing burden of infectious diseases, the rising frequency of sepsis, and expanding government programs to raise sepsis awareness are among the key reasons why it is anticipated that the need for sepsis diagnostic devices would rise. This factor is expected to drive the growth of the Sepsis Diagnostics market.

Browse The Table of Contents And List of Figures At https://reports.valuates.com/market-reports/QYRE-Auto-7F10433/global-sepsis-diagnostics

TRENDS INFLUENCING THE GROWTH OF THE SEPSIS DIAGNOSTICS MARKET

Nosocomial infections, sometimes referred to as hospital-acquired infections or HAIs, are a leading global cause of morbidity and mortality. The most typical hospital-acquired infections (HAIs) are pneumonia, sepsis, and urinary tract infections. In immunocompromised individuals, geriatric patients, and people with chronic conditions, HAIs can result in sepsis. The market for sepsis diagnostic products is anticipated to expand in the upcoming years as a result of the sharp rise in HAIs globally. This factor is expected to drive the growth of the sepsis diagnostics market. 

The development of rapid diagnostic/POC techniques for early sepsis diagnosis will drive the sepsis diagnosis market. Sepsis is a highly challenging condition to detect, and in septic shock patients with hypertension, a delay in antibiotic delivery of even one-minute increases the chance of mortality. Thus, it is more important than ever to make a quick diagnosis of sepsis to speed up the administration of antibiotics to sepsis patients. Many sepsis diagnostic firms are extending the range of products they offer in point-of-care technologies that can diagnose sepsis more quickly in general. 

The Global Sepsis Alliance can more firmly assert that COVID-19 does actually cause sepsis now that there is more scientific information on it available. A dysregulated host response to infection results in sepsis, which is defined as a life-threatening organ malfunction. Although the effects of COVID-19 on the respiratory system are well documented, with the majority of patients needing hospital admission and developing pneumonia of various severity, almost all other organ systems can also be impacted. Thus, this factor will further drive the growth of the Sepsis diagnostics market. 

Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-7F10433/Global_Sepsis_Diagnostics_Market

SEPSIS DIAGNOSTIC MARKET SHARE ANALYSIS

The microbiology segment currently dominates the sepsis diagnostic market by Type and is anticipated to hold its position during the sepsis diagnostic market forecast period. This is explained by the fact that the use of culture medium tests in microbiological technology enables precise detection and identification of bacteria for sepsis diagnosis.

Due to the increased prevalence of sepsis, rapid uptake of expensive sepsis diagnostic tools, and increasing government support for sepsis-related research, North America is anticipated to hold the biggest market share in 2018.

In terms of end users, the hospitals & specialty Clinics category held the greatest market share for sepsis diagnostics in 2021.

Inquire For Customization : https://reports.valuates.com/request/customisation/QYRE-Auto-7F10433/Global_Sepsis_Diagnostics_Market

Market By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Buy Chapter On North America: https://reports.valuates.com/market-reports/QYRE-Auto-7F10433/global-sepsis-diagnostics/6

Buy Chapter On Asia Pacific: https://reports.valuates.com/market-reports/QYRE-Auto-7F10433/global-sepsis-diagnostics/8

Key players

• Biomerieux
• T2 Biosystems
• Luminex
• Becton Dickinson
• Roche
• Danaher
• Thermo Fisher
• Bruker
• Abbott
• Immunexpress
• Response Biomedical
• Axis-Shield Diagnostics
• Cytosorbents
• Mitsubishi Chemical
• EKF Diagnostics

Buy Chapter On Company Profiles: https://reports.valuates.com/market-reports/QYRE-Auto-7F10433/global-sepsis-diagnostics/5

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-7F10433&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

• EPO Biomarkers Industry Research Report
• Genomics Biomarkers Market
• Sepsis Treatment market is projected to reach USD 5307.4 million by 2028 from an estimated USD 3596.6 million in 2022, at a CAGR of 6.7% during 2023 and 2028.
• Sepsis Drug Market
• Sepsis and Septic Shock Treatment Market
• Sepsis Partnering Market
• Sepsis Biomarkers Market
• Sepsis Clinical Testing Market
• Sepsis Therapeutics Industry Research Report
• Synthetic Biology market size is estimated to be worth USD 10060 million in 2022 and is forecast to be a readjusted size of USD 33120 million by 2028 with a CAGR of 22.0% during the review period.
• Genome Editing & Genome Engineering Market is projected to reach a revised size of USD 6739.8 million by 2028, growing at a CAGR of 9.3% during the forecast period 2022-2028.
• Microfluidics Market is projected to reach USD 7397 million by 2028 from an estimated USD 3496.8 million in 2022, at a CAGR of 13.3% during 2023 and 2028.
• Gene Synthesis Market size is projected to reach USD 759 million by 2027, from USD 309.5 million in 2020, at a CAGR of 13.6% during 2021-2027.
• Site Directed Mutagenesis System Market
• 3D Cell Culture Market
• Genome Editing Market is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.
• Cell Analysis Market is projected to reach USD 25610 Million by 2027, from USD 19740 Million in 2020, at a Compound Annual Growth Rate (CAGR) of 3.7% during 2021-2027.
• Cell Culture Market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
• DNA Sequencing Market size was USD 13380 million and it is expected to reach USD 48700 million by the end of 2027, with a CAGR of 20.4% during 2021-2027
• Bioreactors Market is estimated to be worth USD 1523.1 million in 2022 and is forecast to a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.
• Single use Bioprocessing Market is projected to reach USD 6956.3 million by 2027, from USD 3905.3 million in 2020, at a CAGR of 10.1% during 2021-2027.
• Digital PCR Market generated D508.8 million in 2020 and is projected to reach D1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
• Orphan Drugs Market is projected to reach USD 241610 million by 2027, from USD 122720 million in 2020, at a CAGR of 9.7% during 2021-2027.
• Medical Tubing Market is estimated to be worth USD 8136.6 million in 2022 and is forecast to be a readjusted size of USD 13570 million by 2028 with a CAGR of 8.9% during the review period.
• Global Clinical Flow Cytometry Market Research Report 2022
• Flow Cytometry Market estimated at USD 5.1 billion in the year 2022, is projected to reach a revised size of USD 8.4 billion by 2028, growing at a CAGR of 8.7% during the forecast period 2022-2028.
• Antimicrobial susceptibility testing market was valued at USD 3040.00 million in 2020 and is projected to reach USD 4736.03 million by 2030 registering a CAGR of 5.8% from 2021 to 2030.
• Neurostimulation Devices market is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.
• Digital PCR (DPCR) and QPCR market is estimated to be worth USD 1419.2 million in 2022 and is forecast to a readjusted size of USD 2165.8 million by 2028 with a CAGR of 7.3% during the review period.
• Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.v
• Biometrics market is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.
• Fiducial Markers market is estimated to be worth USD 104.8 million in 2022 and is forecast to be a readjusted size of USD 131.4 million by 2028 with a CAGR of 3.9% during the review period
• Dialysis Market was valued at USD 91,205.0 million in 2020 and is estimated to reach USD 129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028.

Click Here To See Related Reports on Sepsis Diagnostics Market

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:

Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports
https://reports.valuates.com/sitemap/html/reports/9
https://reports.valuates.com/sitemap/html/reports/10

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg